Neurocrine Biosciences
NBIX
NBIX
508 hedge funds and large institutions have $10.3B invested in Neurocrine Biosciences in 2023 Q3 according to their latest regulatory filings, with 89 funds opening new positions, 157 increasing their positions, 197 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
508
Holders Change
+54
Holders Change %
+11.89%
% of All Funds
8.1%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.18%
New
89
Increased
157
Reduced
197
Closed
30
Calls
$71.2M
Puts
$54.7M
Net Calls
+$16.5M
Net Calls Change
+$2.59M
Top Buyers
Top Sellers
| 1 |
1
Amundi
Paris,
France
|
$34.5M |
| 2 |
WP
2
Woodline Partners
San Francisco,
California
|
$34.1M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$82.8M |
| 4 |
4
Man Group
London,
United Kingdom
|
$37.6M |
| 5 |
AC
5
Armistice Capital
New York
|
$137M |
